United Therapeutics Target Price

See United Therapeutics's analyst price targets ($520) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$497.59

Average Target Price

$515.00

3.5% upside

1 analysts in the last 4 months

High: $515 | Low: $515

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-06	Morgan StanleyTerence Flynn	$515	3.5% upside
2026-05-07	Morgan StanleyTerence Flynn	$516	3.7% upside
2026-05-07	Wells Fargo	$735	47.7% upside
2026-05-07	Wells Fargo	$738	48.3% upside
2026-04-10	Morgan StanleyTerence Flynn	$519	4.3% upside
2026-04-10	Raymond James	$700	40.7% upside
2026-03-12	Cantor FitzgeraldOlivia Brayer	$625	25.6% upside
2026-02-26	H.C. WainwrightAndrew Fein	$600	20.6% upside
2026-01-06	UBS	$645	29.6% upside
2025-11-19	JefferiesEun Yang	$575	15.6% upside
2025-10-30	H.C. WainwrightAndrew Fein	$525	5.5% upside
2025-10-30	RBC CapitalLisa Walter	$587	18% upside
2025-10-29	Morgan StanleyTerrance Flynn	$447	10.2% downside
2025-10-10	Morgan StanleyTerence Flynn	$435	12.6% downside
2025-09-29	UBS	$580	16.6% upside
2025-09-26	RBC Capital	$569	14.4% upside
2025-09-10	Cantor FitzgeraldOlivia Brayer	$525	5.5% upside
2025-09-05	H.C. WainwrightAndrew Fein	$500	0.5% upside
2025-09-02	JefferiesRoger Song	$564	13.3% upside
2025-07-31	H.C. WainwrightAndrew Fein	$400	19.6% downside
2025-04-25	Wells FargoTiago Fauth	$314	36.9% downside
2024-10-31	Argus ResearchJasper Hellweg	$400	19.6% downside
2024-10-31	H.C. WainwrightAndrew Fein	$425	14.6% downside
2024-09-23	JefferiesEun Yang	$432	13.2% downside
2024-08-28	OppenheimerHartaj Singh	$575	15.6% upside
2024-07-08	UBSAshwani Verma	$370	25.6% downside
2024-06-12	Wells FargoTiago Fauth	$350	29.7% downside
2024-05-02	OppenheimerHartaj Singh	$400	19.6% downside
2024-02-12	Goldman SachsChris Shibutani	$215	56.8% downside
2023-01-11	Argus Research	$300	39.7% downside
2022-12-06	Morgan Stanley	$330	33.7% downside
2022-12-06	UBS	$320	35.7% downside
2022-12-05	Goldman Sachs	$230	53.8% downside
2022-05-24	J.P. Morgan	$238	52.2% downside
2022-05-24	Jefferies	$245	50.8% downside
2022-05-24	Credit Suisse	$247	50.4% downside
2022-05-24	H.C. Wainwright	$255	48.8% downside
2022-04-19	J.P. Morgan	$223	55.2% downside
2021-05-05	Credit SuisseTiago Fauth	$205	58.8% downside

United Therapeutics (UTHR) FAQ

United Therapeutics's target price stands at $520. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $520 for UTHR implies 3.5% upside versus today's price ($497.59). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how United Therapeutics's target price evolved across reporting periods, while the comparison chart places UTHR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. United Therapeutics's reading of $520 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.